PRAISE-IR Versus CIBMTR Controls

Clinical trial NCT07717164 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07717164
Sponsor: Miltenyi Biomedicine GmbH
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

ALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myeloid Leukemia)MDS (Myelodysplastic Syndrome)

Start date: 2026-07-31
Primary completion: 2026-09-20
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.